Hospital groups to sue HHS to block price transparency rule

Hospital groups are not happy about a new HHS requirement that will force all hospitals to publicly post their prices for services online. A group of hospital associations plan to launch a lawsuit against the agency just days after it finalized the rule, which will take effect Jan. 1, 2021.

“…This rule will introduce widespread confusion, accelerate anticompetitive behavior among health insurers and stymie innovations in value-based care delivery,” reads a joint statement from the American Hospital Association (AHA), Association of American Medical Colleges (AAMC), Children’s Hospital Association (CHA) and Federation of American Hospitals (FAH). The associations commented on the rule just hours after the final version was released on Nov. 15.

The rule specifically requires all hospitals to post their prices online for consumers to view and comparison shop. The goal of HHS is to empower patients and consumers with more information to make better healthcare choices and ultimately lower costs.

Hospitals will be required to post standard charges that include payer-specific negotiated charges so consumers can know what to expect to pay with their insurance. The final rule pushed back the proposed implementation date from 2020 to 2021.

Hospitals that don’t comply will face civil monetary penalties of up to $300 per day.

At the time of the final rule issuance, hospital groups were up in arms, arguing the action wouldn’t actually provide patients with real price transparency.

"Patients should have readily available and easy-to-understand cost-sharing information when they need to make healthcare decisions. Healthcare price transparency ought to be defined by the right information at the right time,” FAH President and CEO Chip Kahn said in a statement on Nov. 15. "This final regulation on hospital transparency fails to meet the definition of price transparency useful for patients. Instead, it will only result in patient overload of useless information while distorting the competitive market for purchasing hospital care."

In addition, he argued HHS was overstepping its authority to implement the rule, something that could appear in upcoming legal action from the hospital.

“Because the final rule does not achieve the goal of providing patients with out-of-pocket cost information, and instead threatens to confuse patients, our four organizations will soon join with member hospitals to file a legal challenge to the rule on grounds including that it exceeds the Administration’s authority,” the joint statement concluded.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.